PMV Pharmaceuticals Announces Board Chair Transition
Laurie Stelzer has been appointed Chair of the Board of PMV Pharmaceuticals, effective at the company's 2026 Annual Meeting on June 4, 2026, succeeding Rich Heyman, Ph.D. Dr. Heyman will not stand for reelection, concluding his tenure, while Ms. Stelzer brings over 25 years of financial and biopharmaceutical leadership experience to the role.
Key figures
- Drug Name
- rezatapopt
- Annual meeting date
- June 4, 2026
- Nda submission timeline
- first quarter of 2027
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.